Rock Springs Capital Management’s Aura Biosciences AURA Stock Holding History

Rock Springs Capital Management’s Portfolio AURA Stock Details AURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-722,896	Closed	-$6.48M	–	105
2023 Q3	$6.48M	Sell	722,896 -296,861	-29%	-$3.19M	0.17%	81
2023 Q2	$12.6M	Hold	1,019,757	–	–	0.3%	72
2023 Q1	$9.46M	Hold	1,019,757	–	–	0.23%	77
2022 Q4	$10.7M	Buy	1,019,757 +4,000	+0.4%	+$50.9K	0.26%	71
2022 Q3	$18.4M	Buy	1,015,757 +6,943	+0.7%	+$105K	0.48%	59
2022 Q2	$14.3M	Buy	1,008,814 +700	+0.1%	+$11.6K	0.42%	63
2022 Q1	$22.2M	Hold	1,008,114	–	–	0.56%	58
2021 Q4	$17.1M	Buy	+1,008,114	New	+$18M	0.4%	72

Other funds holding AURA

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MVM

Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

RCM

Regency Capital Management Honolulu, Hawaii $224M AUM 26.03% 1-Year Est. Return

Rock Springs Capital Management's AURA Position: Q4 2023 in Review

Rock Springs Capital Management sold out of Aura Biosciences (AURA) in Q4 2023, closing a stake of 722,896 shares — an estimated $6.48M sold.

Rock Springs Capital Management first reported a position in AURA in Q4 2021 and held it in 8 quarters. The position peaked at $22.2M in Q1 2022. 72 funds tracked by Wall St. Rank hold AURA as of Q4 2023.

Rock Springs Capital Management reported no remaining Aura Biosciences position as of Q4 2023 after selling out during the quarter.
Rock Springs Capital Management sold 722,896 Aura Biosciences shares in Q4 2023, an estimated $6.48M.
Rock Springs Capital Management first reported a position in Aura Biosciences in Q4 2021 and held it in 8 quarters.
Rock Springs Capital Management's Aura Biosciences position peaked at $22.2M in Q1 2022.
72 funds tracked by Wall St. Rank held Aura Biosciences as of Q4 2023.

Based on Rock Springs Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.